Chief Financial Officer and EVP Corp Dev at Affymax - New York, New York, United States
Senior Accountant
Contact Michael Willams
Consultant
Contact Robert Naso
QC manager
Contact Beatrisa Aronchik
Senior Clinical Scientist
Contact Min-Jia Chen
Executive Director, Drug Safety and Pharmacovigilance
Contact Daniel Cooper
RAII
Contact Gayatri Paranjpe
Manager, Clinical Quality Assurance
Contact Karen Chism
Affymax is a New York-based biotechnology company that develops and commercializes novel therapeutics for the treatment of kidney disease.